{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:47:39Z","timestamp":1790189259998,"version":"4.1.0"},"reference-count":37,"publisher":"Tohoku University Medical Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2019]]},"DOI":"10.1620\/tjem.247.75","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T22:43:50Z","timestamp":1548974630000},"page":"75-86","source":"Crossref","is-referenced-by-count":65,"title":["Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone"],"prefix":"10.1620","volume":"247","author":[{"given":"Takahiko","family":"Shibahara","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Tokyo Dental College"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws; American Association of Oral and Maxillofacial Surgeons  (2007)  American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws.  <i>J. Oral Maxillofac. Surg<\/i>., 65, 369-376.","DOI":"10.1016\/j.joms.2006.11.003"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Baron, R., Ferrari, S. &amp; Russell, R.G. (2011)  Denosumab and bisphosphonates: different mechanisms of action and effects.  <i>Bone<\/i>, 48, 677-692.","DOI":"10.1016\/j.bone.2010.11.020"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Bekker, P.J., Holloway, D.L., Rasmussen, A.S., Murphy, R., Martin, S.W., Leese, P.T., Holmes, G.B., Dunstan, C.R. &amp; DePaoli, A.M. (2004)  A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women.  <i>J. Bone Miner. Res<\/i>., 19, 1059-1066.","DOI":"10.1359\/JBMR.040305"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Cardemil, C., Omar, O.M., Norlindh, B., Wexell, C.L. &amp; Thomsen, P. (2013)  The effects of a systemic single dose of zoledronic acid on post-implantation bone remodelling and inflammation in an ovariectomised rat model.  <i>Biomaterials<\/i>, 34, 1546-1561.","DOI":"10.1016\/j.biomaterials.2012.11.003"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Cosman, F., Crittenden, D.B., Adachi, J.D., Binkley, N., Czerwinski, E., Ferrari, S., Hofbauer, L.C., Lau, E., Lewiecki, E.M., Miyauchi, A., Zerbini, C.A., Milmont, C.E., Chen, L., Maddox, J., Meisner, P.D.,  et al. (2016)  Romosozumab treatment in postmenopausal women with osteoporosis.  <i>N. Engl. J. Med<\/i>., 375, 1532-1543.","DOI":"10.1056\/NEJMoa1607948"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Cummings, S.R., San Martin, J., McClung, M.R., Siris, E.S., Eastell, R., Reid, I.R., Delmas, P., Zoog, H.B., Austin, M., Wang, A., Kutilek, S., Adami, S., Zanchetta, J., Libanati, C., Siddhanti, S.,  et al. (2009)  Denosumab for prevention of fractures in postmenopausal women with osteoporosis.  <i>N. Engl. J. Med<\/i>., 361, 756-765.","DOI":"10.1056\/NEJMoa0809493"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Dhanda, J., Pasquier, D., Newman, L. &amp; Shaw, R. (2016)  Current concepts in osteoradionecrosis after head and neck radiotherapy.  <i>Clin. Oncol<\/i>. (<i>R. Coll. Radiol.<\/i>), 28, 459-466.","DOI":"10.1016\/j.clon.2016.03.002"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Fedele, S., Porter, S.R., D\u2019Aiuto, F., Aljohani, S., Vescovi, P., Manfredi, M., Arduino, P.G., Broccoletti, R., Musciotto, A., Di Fede, O., Lazarovici, T.S., Campisi, G. &amp; Yarom, N. (2010)  Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.  <i>Am. J. Med<\/i>., 123, 1060-1064.","DOI":"10.1016\/j.amjmed.2010.04.033"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Filleul, O., Crompot, E. &amp; Saussez, S. (2010)  Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases.  <i>J. Cancer Res. Clin. Oncol<\/i>., 136, 1117-1124.","DOI":"10.1007\/s00432-010-0907-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Fizazi, K., Carducci, M., Smith, M., Damiao, R., Brown, J., Karsh, L., Milecki, P., Shore, N., Rader, M., Wang, H., Jiang, Q., Tadros, S., Dansey, R. &amp; Goessl, C. (2011)  Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.  <i>Lancet<\/i>, 377, 813-822.","DOI":"10.1016\/S0140-6736(10)62344-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Fleisch, H. (1998)  Bisphosphonates: mechanisms of action.  <i>Endocr. Rev<\/i>., 19, 80-100.","DOI":"10.1210\/edrv.19.1.0325"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Fleisch, H. (2002)  Development of bisphosphonates.  <i>Breast Cancer Res<\/i>., 4, 30-34.","DOI":"10.1186\/bcr414"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Hasegawa, T., Kawakita, A., Ueda, N., Funahara, R., Tachibana, A., Kobayashi, M., Kondou, E., Takeda, D., Kojima, Y., Sato, S., Yanamoto, S., Komatsubara, H., Umeda, M., Kirita, T., Kurita, H.,  et al. (2017)  A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?  <i>Osteoporos. Int<\/i>., 28, 2465-2473.","DOI":"10.1007\/s00198-017-4063-7"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Hellstein, J.W., Adler, R.A., Edwards, B., Jacobsen, P.L., Kalmar, J.R., Koka, S., Migliorati, C.A. &amp; Ristic, H.; American Dental Association Council on Scientific Affairs Expert Panel on Antiresorptive Agents  (2011)  Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs.  <i>J. Am. Dent. Assoc<\/i>., 142, 1243-1251.","DOI":"10.14219\/jada.archive.2011.0108"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Henry, D.H., Costa, L., Goldwasser, F., Hirsh, V., Hungria, V., Prausova, J., Scagliotti, G.V., Sleeboom, H., Spencer, A., Vadhan-Raj, S., von Moos, R., Willenbacher, W., Woll, P.J., Wang, J., Jiang, Q.,  et al. (2011)  Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma.  <i>J. Clin. Oncol<\/i>., 29, 1125-1132.","DOI":"10.1200\/JCO.2010.31.3304"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Katsura, K., Sasai, K., Sato, K., Saito, M., Hoshina, H. &amp; Hayashi, T. (2008)  Relationship between oral health status and development of osteoradionecrosis of the mandible: a retrospective longitudinal study.  <i>Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod<\/i>., 105, 731-738.","DOI":"10.1016\/j.tripleo.2007.10.011"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Khan, A.A., Morrison, A., Kendler, D.L., Rizzoli, R., Hanley, D.A., Felsenberg, D., McCauley, L.K., O\u2019Ryan, F., Reid, I.R., Ruggiero, S.L., Taguchi, A., Tetradis, S., Watts, N.B., Brandi, M.L., Peters, E.,  et al. (2017)  Case-based review of osteonecrosis of the jaw (ONJ) and application of the international recommendations for management from the international task force on ONJ.  <i>J. Clin. Densitom<\/i>., 20, 8-24.","DOI":"10.1016\/j.jocd.2016.09.005"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Khan, S.A., Kanis, J.A., Vasikaran, S., Kline, W.F., Matuszewski, B.K., McCloskey, E.V., Beneton, M.N., Gertz, B.J., Sciberras, D.G., Holland, S.D., Orgee, J., Coombes, G.M., Rogers, S.R. &amp; Porras, A.G. (1997)  Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis.  <i>J. Bone Miner. Res<\/i>., 12, 1700-1707.","DOI":"10.1359\/jbmr.1997.12.10.1700"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Koga, D.H., Salvajoli, J.V. &amp; Alves, F.A. (2008)  Dental extractions and radiotherapy in head and neck oncology: review of the literature.  <i>Oral Dis<\/i>., 14, 40-44.","DOI":"10.1111\/j.1601-0825.2006.01351.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Marx, R.E. (1983)  Osteoradionecrosis: a new concept of its pathophysiology.  <i>J. Oral Maxillofac. Surg<\/i>., 41, 283-288.","DOI":"10.1016\/0278-2391(83)90294-X"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Marx, R.E. (2003)  Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.  <i>J. Oral Maxillofac. Surg<\/i>., 61, 1115-1117.","DOI":"10.1016\/S0278-2391(03)00720-1"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Mavrokokki, T., Cheng, A., Stein, B. &amp; Goss, A. (2007)  Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.  <i>J. Oral Maxillofac. Surg<\/i>., 65, 415-423.","DOI":"10.1016\/j.joms.2006.10.061"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Nicolatou-Galitis, O., Kouri, M., Papadopoulou, E., Vardas, E., Galiti, D., Epstein, J.B., Elad, S., Campisi, G., Tsoukalas, N., Bektas-Kayhan, K., Tan, W., Body, J.J., Migliorati, C. &amp; Lalla, R.V.;  MASCC Bone Study Group  (2019)  Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.  <i>Support. Care Cancer<\/i>, 27, 383-394.","DOI":"10.1007\/s00520-018-4501-x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Niimi, R., Kono, T., Nishihara, A., Hasegawa, M., Kono, T. &amp; Sudo, A. (2018)  Rebound-associated vertebral fractures after discontinuation of denosumab for the treatment of maxillitis.  <i>Osteoporos. Int<\/i>., 29, 769-772.","DOI":"10.1007\/s00198-017-4334-3"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Ristow, O., Gerngross, C., Schwaiger, M., Hohlweg-Majert, B., Kehl, V., Jansen, H., Hahnefeld, L., Koerdt, S., Otto, S. &amp; Pautke, C. (2014)  Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates.  <i>Br. J. Oral Maxillofac. Surg<\/i>., 52, 308-313.","DOI":"10.1016\/j.bjoms.2014.01.021"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Rosen, L.S., Gordon, D., Tchekmedyian, S., Yanagihara, R., Hirsh, V., Krzakowski, M., Pawlicki, M., de Souza, P., Zheng, M., Urbanowitz, G., Reitsma, D. &amp; Seaman, J.J. (2003)  Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial \u2013 the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group.  <i>J. Clin. Oncol<\/i>., 21, 3150-3157.","DOI":"10.1200\/JCO.2003.04.105"},{"key":"27","unstructured":"Ruggiero, S.L., Dodson, T.B., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B. &amp; O\u2019Ryan, F.; American Association of Oral and Maxillofacial Surgeons  (2014)  American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw: 2014 update.  <i>J. Oral Maxillofac. Surg<\/i>., 72, 1938-1956."},{"key":"28","doi-asserted-by":"crossref","unstructured":"Saag, K.G., Petersen, J., Brandi, M.L., Karaplis, A.C., Lorentzon, M., Thomas, T., Maddox, J., Fan, M., Meisner, P.D. &amp; Grauer, A. (2017)  Romosozumab or alendronate for fracture prevention in women with osteoporosis.  <i>N. Engl. J. Med<\/i>., 377, 1417-1427.","DOI":"10.1056\/NEJMoa1708322"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Shibahara, T., Morikawa, T., Yago, K., Kishimoto, H., Imai, Y. &amp; Kurita, K. (2018)  National survey on bisphosphonate-related osteonecrosis of the jaws in Japan.  <i>J. Oral Maxillofac. Surg<\/i>., 76, 2105-2112.","DOI":"10.1016\/j.joms.2018.04.009"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Stopeck, A.T., Fizazi, K., Body, J.J., Brown, J.E., Carducci, M., Diel, I., Fujiwara, Y., Martin, M., Paterson, A., Tonkin, K., Shore, N., Sieber, P., Kueppers, F., Karsh, L., Yardley, D.,  et al. (2016)  Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.  <i>Support. Care Cancer<\/i>, 24, 447-455.","DOI":"10.1007\/s00520-015-2904-5"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Taylor, K.H., Middlefell, L.S. &amp; Mizen, K.D. (2010)  Osteonecrosis of the jaws induced by anti-RANK ligand therapy.  <i>Br. J. Oral Maxillofac. Surg<\/i>., 48, 221-223.","DOI":"10.1016\/j.bjoms.2009.08.030"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Urade, M., Tanaka, N., Furusawa, K., Shimada, J., Shibata, T., Kirita, T., Yamamoto, T., Ikebe, T., Kitagawa, Y. &amp; Fukuta, J. (2011)  Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.  <i>J. Oral Maxillofac. Surg<\/i>., 69, e364-371.","DOI":"10.1016\/j.joms.2011.03.051"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Van Poznak, C.H., Temin, S., Yee, G.C., Janjan, N.A., Barlow, W.E., Biermann, J.S., Bosserman, L.D., Geoghegan, C., Hillner, B.E., Theriault, R.L., Zuckerman, D.S. &amp; Von Roenn, J.H.; American Society of Clinical Oncology (2011)  American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer. <i>J. Clin. Oncol<\/i>., 29, 1221-1227.","DOI":"10.1200\/JCO.2010.32.5209"},{"key":"34","unstructured":"Yamaguchi, A., Kubo, S., Matsunaga, T. &amp; Shibahara, T. (2018)  Report by the jaw bone disease project 1: concept, diagnosis and treatment of medication-related osteonecrosis of the jaw.  <i>The Shikwa Gakuho<\/i>, 118, 165-176 (in Japanese, abstract in English)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahashi, N.,  et al. (1998)  Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL.  <i>Proc. Natl. Acad. Sci. USA<\/i>, 95, 3597-3602.","DOI":"10.1073\/pnas.95.7.3597"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Yoneda, T., Hagino, H., Sugimoto, T., Ohta, H., Takahashi, S., Soen, S., Taguchi, A., Nagata, T., Urade, M., Shibahara, T. &amp; Toyosawa, S. (2017)  Antiresorptive agent-related osteonecrosis of the jaw: position paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw.  <i>J. Bone Miner. Metab<\/i>., 35, 6-19.","DOI":"10.1007\/s00774-016-0810-7"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Yoneda, T., Hagino, H., Sugimoto, T., Ohta, H., Takahashi, S., Soen, S., Taguchi, A., Toyosawa, S., Nagata, T. &amp; Urade, M. (2010)  Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons.  <i>J. Bone Miner. Metab<\/i>., 28, 365-383.","DOI":"10.1007\/s00774-010-0162-7"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/247\/2\/247_75\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T05:35:07Z","timestamp":1549085707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/247\/2\/247_75\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.247.75","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}